• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

March 2005: Additions and Deletions to the Drug Product List

24th Edition: Cumulative Supplement Number 3

[Prescription - OTC]

NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.



ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

       ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
          TABLET; ORAL
>A>         ACETAMINOPHEN AND TRAMADOL HCL
>A>   AB      KALI LABS                  325MG;37.5MG                            N76475 001  Apr 21, 2005    Mar  NEWA
            ULTRACET
>D>       +   ORTHO MCNEIL               325MG;37.5MG                            N21123 001  Aug 15, 2001    Mar  CFTG
>A>   AB  +                              325MG;37.5MG                            N21123 001  Aug 15, 2001    Mar  CFTG


        ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
          CAPSULE; ORAL
            SEMPREX-D
>D>       +   CELLTECH PHARMS            8MG;60MG                                N19806 001  Mar 25, 1994    Mar  CAHN
>A>       +   UCB                        8MG;60MG                                N19806 001  Mar 25, 1994    Mar  CAHN

        ACYCLOVIR
          CAPSULE; ORAL
            ACYCLOVIR
>D>   AB      COPLEY PHARM               200MG                                   N74914 001  Nov 26, 1997    Mar  CAHN

>A>   AB      TEVA PHARMS                200MG                                   N74914 001  Nov 26, 1997    Mar  CAHN
          TABLET; ORAL
            ACYCLOVIR
>D>   AB      COPLEY PHARM               400MG                                   N75021 001  Mar 18, 1998    Mar  CAHN
>D>   AB                                 800MG                                   N75021 002  Mar 18, 1998    Mar  CAHN
>A>   AB      TEVA PHARMS                400MG                                   N75021 001  Mar 18, 1998    Mar  CAHN
>A>   AB                                 800MG                                   N75021 002  Mar 18, 1998    Mar  CAHN


        AMANTADINE HYDROCHLORIDE
          SYRUP; ORAL
            AMANTADINE HCL
>D>   AA      COPLEY PHARM               50MG/5ML                                N73115 001  Aug 23, 1991    Mar  CAHN
>A>   AA      TEVA PHARMS                50MG/5ML                                N73115 001  Aug 23, 1991    Mar  CAHN

        AMINO ACIDS
          INJECTABLE; INJECTION
            AMINOSYN 7%
>D>         @ HOSPIRA                    7% (7GM/100ML)                          N17673 002                  Mar  CMFD

>A>                                      7% (7GM/100ML)                          N17673 002                  Mar  CMFD
            AMINOSYN 8.5%
>D>         @ HOSPIRA                    8.5% (8.5GM/100ML)                      N17673 004                  Mar  CMFD
>A>                                      8.5% (8.5GM/100ML)                      N17673 004                  Mar  CMFD

        AMIODARONE
          INJECTABLE; INTRAVENOUS
            AMIODARONE HCL
>A>   AP      APOTEX                     50MG/ML                                 N77161 001  Apr 20, 2005    Mar  NEWA


        AMIODARONE HYDROCHLORIDE
          INJECTABLE; INJECTION
            AMIODARONE HCL
>D>   AP      AM PHARM PARTNERS          50MG/ML                                 N75761 001  Oct 15, 2002    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N75761 001  Oct 15, 2002    Mar  CRLD
>D>   AP      APOTEX                     50MG/ML                                 N76394 001  Apr 25, 2003    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76394 001  Apr 25, 2003    Mar  CRLD
>D>   AP      BEDFORD                    50MG/ML                                 N76018 001  Oct 15, 2002    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76018 001  Oct 15, 2002    Mar  CRLD
>D>   AP      BEDFORD LABS               50MG/ML                                 N76299 001  Oct 24, 2002    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76299 001  Oct 24, 2002    Mar  CRLD
>D>   AP      BEN VENUE                  50MG/ML                                 N76088 001  Oct 15, 2002    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76088 001  Oct 15, 2002    Mar  CRLD
>D>   AP      BIONICHE (CANADA)          50MG/ML                                 N76217 001  Oct 15, 2002    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76217 001  Oct 15, 2002    Mar  CRLD
>D>   AP      MAYNE PHARMA USA           50MG/ML                                 N76108 001  Oct 15, 2002    Mar  CRLD
>A>   AP  +   MAYNE PHARMA USA           50MG/ML                                 N76108 001  Oct 15, 2002    Mar  CRLD
>D>   AP      SICOR PHARMS               50MG/ML                                 N76163 001  Sep 05, 2003    Mar  CRLD
>A>   AP  +                              50MG/ML                                 N76163 001  Sep 05, 2003    Mar  CRLD
          TABLET; ORAL
            AMIODARONE HCL
>A>   AB      AUROSAL PHARMS             200MG                                   N77069 001  Apr 08, 2005    Mar  NEWA
>A>   AB                                 400MG                                   N77069 002  Apr 08, 2005    Mar  NEWA
>D>   AB      COPLEY PHARM               200MG                                   N74739 001  Nov 30, 1998    Mar  CAHN
>D>           TARO                       100MG                                   N75424 002  Dec 18, 2002    Mar  CTEC
>A>   AB                                 100MG                                   N75424 002  Dec 18, 2002    Mar  CTEC
>A>   AB      TEVA PHARMS                200MG                                   N74739 001  Nov 30, 1998    Mar  CAHN
            PACERONE
>A>   AB      UPSHER SMITH               100MG                                   N75135 002  Apr 12, 2005    Mar  NEWA


        ANAGRELIDE HYDROCHLORIDE
          CAPSULE; ORAL
            AGRYLIN
>D>           SHIRE                      EQ 0.5MG BASE                           N20333 001  Mar 14, 1997    Mar  CFTG
>A>   AB                                 EQ 0.5MG BASE                           N20333 001  Mar 14, 1997    Mar  CFTG
>D>       +                              EQ 1MG BASE                             N20333 002  Mar 14, 1997    Mar  CFTG
>A>   AB  +                              EQ 1MG BASE                             N20333 002  Mar 14, 1997    Mar  CFTG
>A>         ANAGRELIDE HCL
>A>   AB      BARR                       EQ 0.5MG BASE                           N76530 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76530 002  Apr 18, 2005    Mar  NEWA
>A>   AB      EON                        EQ 0.5MG BASE                           N76683 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76683 002  Apr 18, 2005    Mar  NEWA
>A>   AB      IMPAX LABS                 EQ 0.5MG BASE                           N76910 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76910 002  Apr 18, 2005    Mar  NEWA
>A>   AB      IVAX PHARMS                EQ 0.5MG BASE                           N76468 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76468 002  Apr 18, 2005    Mar  NEWA
>A>   AB      MYLAN                      EQ 0.5MG BASE                           N76811 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76811 002  Apr 18, 2005    Mar  NEWA
>A>   AB      ROXANE                     EQ 0.5MG BASE                           N76489 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76489 002  Apr 18, 2005    Mar  NEWA
>A>   AB      WATSON LABS                EQ 0.5MG BASE                           N76417 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 EQ 1MG BASE                             N76417 002  Apr 18, 2005    Mar  NEWA


        ATENOLOL
          TABLET; ORAL
            ATENOLOL
>D>   AB      COPLEY PHARM               50MG                                    N74120 001  Feb 24, 1995    Mar  CAHN
>D>   AB                                 100MG                                   N74120 002  Feb 24, 1995    Mar  CAHN
>D>           MYLAN                      25MG                                    N73457 002  Apr 26, 1999    Mar  CTEC
>A>   AB                                 25MG                                    N73457 002  Apr 26, 1999    Mar  CTEC
>A>   AB      TEVA PHARMS                50MG                                    N74120 001  Feb 24, 1995    Mar  CAHN
>A>   AB                                 100MG                                   N74120 002  Feb 24, 1995    Mar  CAHN


>D>     BENZYL PENICILLOYL-POLYLYSINE
>D>       INJECTABLE; INJECTION
>D>         PRE-PEN
>D>       +   HOLLISTER STIER            60UMOLAR                                N50114 001                  Mar  DISC
>A>         @                            60UMOLAR                                N50114 001                  Mar  DISC


        BETAMETHASONE DIPROPIONATE
          LOTION; TOPICAL
            BETAMETHASONE DIPROPIONATE
>D>   AB      COPLEY PHARM               EQ 0.05% BASE                           N71882 001  Jun 06, 1988    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 0.05% BASE                           N71882 001  Jun 06, 1988    Mar  CAHN

        BETAMETHASONE VALERATE
          LOTION; TOPICAL
            BETAMETHASONE VALERATE
>D>   AB      COPLEY PHARM               EQ 0.1% BASE                            N71883 001  Apr 22, 1988    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 0.1% BASE                            N71883 001  Apr 22, 1988    Mar  CAHN


        BISOPROLOL FUMARATE
          TABLET; ORAL
            BISOPROLOL FUMARATE
>D>   AB      COPLEY PHARM               5MG                                     N75644 001  Jun 26, 2001    Mar  CAHN

>D>   AB      COPLEY PHARM               10MG                                    N75644 002  Jun 26, 2001    Mar  CAHN
>A>   AB      TEVA PHARMS                5MG                                     N75644 001  Jun 26, 2001    Mar  CAHN
>A>   AB                                 10MG                                    N75644 002  Jun 26, 2001    Mar  CAHN

>A>     BROMFENAC SODIUM
>A>       SOLUTION/DROPS; OPHTHALMIC
>A>         XIBROM
>A>       +   ISTA PHARMS                0.09%                                   N21664 001  Mar 24, 2005    Mar  NEWA


        BROMOCRIPTINE MESYLATE
          CAPSULE; ORAL
            BROMOCRIPTINE MESYLATE
>A>   AB      MYLAN                      EQ 5MG BASE                             N77226 001  Apr 04, 2005    Mar  NEWA
            PARLODEL
>D>       +   NOVARTIS                   EQ 5MG BASE                             N17962 002  Mar 01, 1982    Mar  CTEC
>A>   AB  +                              EQ 5MG BASE                             N17962 002  Mar 01, 1982    Mar  CTEC


        CAPTOPRIL
          TABLET; ORAL
            CAPTOPRIL
>D>   AB      COPLEY PHARM               12.5MG                                  N74462 001  Feb 13, 1996    Mar  CAHN
>D>   AB                                 25MG                                    N74462 002  Feb 13, 1996    Mar  CAHN
>D>   AB                                 50MG                                    N74462 003  Feb 13, 1996    Mar  CAHN
>D>   AB                                 100MG                                   N74462 004  Feb 13, 1996    Mar  CAHN
>A>   AB      TEVA PHARMS                12.5MG                                  N74462 001  Feb 13, 1996    Mar  CAHN
>A>   AB                                 25MG                                    N74462 002  Feb 13, 1996    Mar  CAHN
>A>   AB                                 50MG                                    N74462 003  Feb 13, 1996    Mar  CAHN
>A>   AB                                 100MG                                   N74462 004  Feb 13, 1996    Mar  CAHN

        CARBAMAZEPINE
          SUSPENSION; ORAL
            CARBAMAZEPINE
>D>   AB      TARO                       100MG/5ML                               N75875 001  Dec 21, 2000    Mar  DISC
>A>         @                            100MG/5ML                               N75875 001  Dec 21, 2000    Mar  DISC


        CARBOPLATIN
          INJECTABLE; INJECTION
            CARBOPLATIN
>A>   AP      EON                        50MG/VIAL                               N76959 001  Mar 18, 2005    Mar  NEWA
>A>   AP                                 150MG/VIAL                              N76959 002  Mar 18, 2005    Mar  NEWA
>A>   AP                                 450MG/VIAL                              N76959 003  Mar 18, 2005    Mar  NEWA


        CEFACLOR
          CAPSULE; ORAL
>D>         CECLOR
>D>   AB      LILLY                      EQ 250MG BASE                           N50521 001                  Mar  DISC
>A>         @                            EQ 250MG BASE                           N50521 001                  Mar  DISC
>D>   AB  +                              EQ 500MG BASE                           N50521 002                  Mar  DISC
>A>         @                            EQ 500MG BASE                           N50521 002                  Mar  DISC
            CEFACLOR
>D>   AB      RANBAXY                    EQ 500MG BASE                           N64156 002  Aug 28, 1997    Mar  CRLD

>A>   AB  +                              EQ 500MG BASE                           N64156 002  Aug 28, 1997    Mar  CRLD
          FOR SUSPENSION; ORAL
            CECLOR
>D>   AB  +   CEPH INTL                  EQ 375MG BASE/5ML                       N62206 004  Apr 20, 1988    Mar  CRLD
>A>   AB                                 EQ 375MG BASE/5ML                       N62206 004  Apr 20, 1988    Mar  CRLD
>D>   AB      LILLY                      EQ 125MG BASE/5ML                       N50522 001                  Mar  DISC
>A>         @                            EQ 125MG BASE/5ML                       N50522 001                  Mar  DISC
>D>   AB  +                              EQ 250MG BASE/5ML                       N50522 002                  Mar  DISC
>A>         @                            EQ 250MG BASE/5ML                       N50522 002                  Mar  DISC
            CEFACLOR
>D>   AB      RANBAXY                    EQ 375MG BASE/5ML                       N64155 001  Oct 02, 1997    Mar  CRLD
>A>   AB  +                              EQ 375MG BASE/5ML                       N64155 001  Oct 02, 1997    Mar  CRLD

        CEFAZOLIN SODIUM
          INJECTABLE; INJECTION
            CEFAZOLIN SODIUM
>D>   AP      AM PHARM PARTNERS          EQ 500MG BASE/VIAL                      N64169 001  Aug 14, 1998    Mar  CRLD
>A>   AP  +                              EQ 500MG BASE/VIAL                      N64169 001  Aug 14, 1998    Mar  CRLD
>D>   AP                                 EQ 1GM BASE/VIAL                        N64169 002  Aug 14, 1998    Mar  CRLD

>A>   AP  +   AM PHARM PARTNERS          EQ 1GM BASE/VIAL                        N64169 002  Aug 14, 1998    Mar  CRLD
>D>   AP                                 EQ 10GM BASE/VIAL                       N64170 001  Mar 18, 1998    Mar  CRLD
>A>   AP  +                              EQ 10GM BASE/VIAL                       N64170 001  Mar 18, 1998    Mar  CRLD

        CEPHALEXIN
          CAPSULE; ORAL
            CEPHALEXIN
>D>   AB      APOTHECON                  EQ 250MG BASE                           N63186 001  Dec 30, 1994    Mar  DISC
>A>         @                            EQ 250MG BASE                           N63186 001  Dec 30, 1994    Mar  DISC
>D>   AB                                 EQ 500MG BASE                           N63186 002  Dec 30, 1994    Mar  DISC
>A>         @                            EQ 500MG BASE                           N63186 002  Dec 30, 1994    Mar  DISC

        CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
          SUSPENSION, EXTENDED RELEASE; ORAL
            CODEPREX
>D>       +   CELLTECH PHARMS            EQ 4MG MALEATE/5ML;EQ 20MG              N21369 001  Jun 21, 2004    Mar  CAHN
>A>       +   UCB                        EQ 4MG MALEATE/5ML;EQ 20MG              N21369 001  Jun 21, 2004    Mar  CAHN

        CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
          SUSPENSION, EXTENDED RELEASE; ORAL
            TUSSIONEX
>D>       +   CELLTECH PHARMS            EQ 8MG MALEATE/5ML;EQ 10MG              N19111 001  Dec 31, 1987    Mar  CAHN
                                         BITARTRATE/5ML
>A>       +   UCB                        EQ 8MG MALEATE/5ML;EQ 10MG              N19111 001  Dec 31, 1987    Mar  CAHN
                                         BITARTRATE/5ML


        CHOLESTYRAMINE
          POWDER; ORAL
            CHOLESTYRAMINE
>D>   AB      COPLEY PHARM               EQ 4GM RESIN/PACKET                     N74554 001  Oct 02, 1996    Mar  CAHN
>D>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N74554 002  Oct 02, 1996    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 4GM RESIN/PACKET                     N74554 001  Oct 02, 1996    Mar  CAHN
>A>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N74554 002  Oct 02, 1996    Mar  CAHN
            CHOLESTYRAMINE LIGHT
>D>   AB      COPLEY PHARM               EQ 4GM RESIN/PACKET                     N74555 001  Sep 30, 1998    Mar  CAHN
>D>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N74555 002  Sep 30, 1998    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 4GM RESIN/PACKET                     N74555 001  Sep 30, 1998    Mar  CAHN
>A>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N74555 002  Sep 30, 1998    Mar  CAHN

        CICLOPIROX
          CREAM; TOPICAL
            CICLOPIROX
>A>   AB      TARO                       0.77%                                   N76790 001  Apr 12, 2005    Mar  NEWA


        CIMETIDINE HYDROCHLORIDE
          SOLUTION; ORAL
            CIMETIDINE HCL
>D>   AA      COPLEY PHARM               EQ 300MG BASE/5ML                       N74859 001  Jul 09, 1998    Mar  CAHN
>A>   AA      TEVA PHARMS                EQ 300MG BASE/5ML                       N74859 001  Jul 09, 1998    Mar  CAHN

        CLEMASTINE FUMARATE
          SYRUP; ORAL
            CLEMASTINE FUMARATE
>D>   AA      COPLEY PHARM               EQ 0.5MG BASE/5ML                       N73095 001  Apr 21, 1992    Mar  CAHN
>A>   AA      TEVA PHARMS                EQ 0.5MG BASE/5ML                       N73095 001  Apr 21, 1992    Mar  CAHN

        CLINDAMYCIN PHOSPHATE
          INJECTABLE; INJECTION
            CLINDAMYCIN PHOSPHATE
>D>         @ HOSPIRA                    EQ 150MG BASE/ML                        N62943 001  Sep 29, 1988    Mar  CMFD
>A>   AP                                 EQ 150MG BASE/ML                        N62943 001  Sep 29, 1988    Mar  CMFD


        CLOBETASOL PROPIONATE
          CREAM; TOPICAL
            CLOBETASOL PROPIONATE
>D>   AB1     COPLEY PHARM               0.05%                                   N74087 001  Feb 16, 1994    Mar  CAHN
>A>   AB1     TEVA PHARMS                0.05%                                   N74087 001  Feb 16, 1994    Mar  CAHN
          OINTMENT; TOPICAL
            CLOBETASOL PROPIONATE
>D>   AB      COPLEY PHARM               0.05%                                   N74089 001  Feb 16, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                0.05%                                   N74089 001  Feb 16, 1994    Mar  CAHN

        CROMOLYN SODIUM
          SOLUTION, CONCENTRATE; ORAL
            GASTROCROM
>D>       +   CELLTECH PHARMS            100MG/5ML                               N20479 001  Feb 29, 1996    Mar  CAHN
>A>       +   UCB                        100MG/5ML                               N20479 001  Feb 29, 1996    Mar  CAHN


        CYCLOSPORINE
          CAPSULE; ORAL
            CYCLOSPORINE
>A>   AB1     IVAX PHARMS                25MG                                    N65110 003  Mar 29, 2005    Mar  NEWA
>A>   AB1                                50MG                                    N65110 001  Mar 29, 2005    Mar  NEWA
>A>   AB1                                100MG                                   N65110 002  Mar 29, 2005    Mar  NEWA
            GENGRAF
>D>   BX      ABBOTT                     50MG                                    N65003 002  May 12, 2000    Mar  CTEC
>A>   AB1                                50MG                                    N65003 002  May 12, 2000    Mar  CTEC

          SOLUTION; ORAL
            CYCLOSPORINE
>A>   AB1     IVAX PHARMS                100MG/ML                                N65078 001  Mar 25, 2005    Mar  NEWA
>D>     DESIRUDIN
>D>       INJECTABLE; SUBCUTANEOUS
>D>         IPRIVASK
>D>       +   CANYON                     15MG/VIAL                               N21271 001  Apr 04, 2003    Mar  CAIN


>A>     DESIRUDIN RECOMBINANT
>A>       INJECTABLE; SUBCUTANEOUS
>A>         IPRIVASK
>A>       +   CANYON                     15MG/VIAL                               N21271 001  Apr 04, 2003    Mar  CAIN

        DESLORATADINE; PSEUDOEPHEDRINE SULFATE
>A>       TABLET, EXTENDED RELEASE; ORAL
>A>         CLARINEX D 24 HOUR
>A>       +   SCHERING                   5MG;240MG                               N21605 001  Mar 03, 2005    Mar  NEWA


        DESONIDE
          CREAM; TOPICAL
            DESONIDE
>D>   AB      COPLEY PHARM               0.05%                                   N74027 001  Sep 28, 1992    Mar  CAHN
>A>   AB      TEVA PHARMS                0.05%                                   N74027 001  Sep 28, 1992    Mar  CAHN

        DEXAMETHASONE
          TABLET; ORAL
            DEXAMETHASONE
>D>       +   PAR PHARM                  0.25MG                                  N88149 001  Apr 28, 1983    Mar  CRLD
>A>                                      0.25MG                                  N88149 001  Apr 28, 1983    Mar  CRLD

>D>   BP  +   ROXANE                     1.5MG                                   N84610 001                  Mar  CRLD
>A>   BP                                 1.5MG                                   N84610 001                  Mar  CRLD

        DEXTROSE
          INJECTABLE; INJECTION
            DEXTROSE 50% IN PLASTIC CONTAINER
>D>         @ HOSPIRA                    500MG/ML                                N19445 001  Jun 03, 1986    Mar  CMFD
>A>   AP                                 500MG/ML                                N19445 001  Jun 03, 1986    Mar  CMFD


        DICLOFENAC SODIUM
          TABLET, DELAYED RELEASE; ORAL
            DICLOFENAC SODIUM
>D>   AB      COPLEY PHARM               25MG                                    N74459 001  Jun 25, 1997    Mar  CAHN
>D>   AB                                 50MG                                    N74459 002  Jun 25, 1997    Mar  CAHN
>D>   AB                                 75MG                                    N74459 003  Jun 25, 1997    Mar  CAHN
>A>   AB      TEVA PHARMS                25MG                                    N74459 001  Jun 25, 1997    Mar  CAHN
>A>   AB                                 50MG                                    N74459 002  Jun 25, 1997    Mar  CAHN
>A>   AB                                 75MG                                    N74459 003  Jun 25, 1997    Mar  CAHN

        DICYCLOMINE HYDROCHLORIDE
          SYRUP; ORAL
            BENTYL
>D>       +   AXCAN SCANDIPHARM          10MG/5ML                                N07961 002  Oct 15, 1984    Mar  CTEC
>A>   AA  +   AXCAN SCANDIPHARM          10MG/5ML                                N07961 002  Oct 15, 1984    Mar  CTEC
>A>         DICYCLOMINE HCL
>A>   AA      MIKART                     10MG/5ML                                N40169 001  Mar 24, 2005    Mar  NEWA

        DILTIAZEM HYDROCHLORIDE
          INJECTABLE; INJECTION
            CARDIZEM
>D>   AP  +   BIOVAIL                    5MG/ML                                  N20027 001  Oct 24, 1991    Mar  CAHN
>D>       +                              25MG/VIAL                               N20027 003  Aug 18, 1995    Mar  CAHN
>A>   AP  +   BIOVAIL LABS INTL          5MG/ML                                  N20027 001  Oct 24, 1991    Mar  CAHN
>A>       +                              25MG/VIAL                               N20027 003  Aug 18, 1995    Mar  CAHN
          TABLET, EXTENDED RELEASE; ORAL
            CARDIZEM LA
>D>           BIOVAIL                    120MG                                   N21392 001  Feb 06, 2003    Mar  CAHN
>D>                                      180MG                                   N21392 002  Feb 06, 2003    Mar  CAHN
>D>                                      240MG                                   N21392 003  Feb 06, 2003    Mar  CAHN
>D>                                      300MG                                   N21392 004  Feb 06, 2003    Mar  CAHN
>D>                                      360MG                                   N21392 005  Feb 06, 2003    Mar  CAHN
>D>       +                              420MG                                   N21392 006  Feb 06, 2003    Mar  CAHN
>A>           BIOVAIL LABS INTL          120MG                                   N21392 001  Feb 06, 2003    Mar  CAHN
>A>                                      180MG                                   N21392 002  Feb 06, 2003    Mar  CAHN
>A>                                      240MG                                   N21392 003  Feb 06, 2003    Mar  CAHN
>A>                                      300MG                                   N21392 004  Feb 06, 2003    Mar  CAHN
>A>                                      360MG                                   N21392 005  Feb 06, 2003    Mar  CAHN
>A>       +                              420MG                                   N21392 006  Feb 06, 2003    Mar  CAHN
          TABLET; ORAL
            CARDIZEM
>D>   AB      BIOVAIL                    30MG                                    N18602 001  Nov 05, 1982    Mar  CAHN
>D>   AB                                 60MG                                    N18602 002  Nov 05, 1982    Mar  CAHN
>D>   AB                                 90MG                                    N18602 003  Dec 08, 1986    Mar  CAHN
>D>   AB  +                              120MG                                   N18602 004  Dec 08, 1986    Mar  CAHN
>A>   AB      BIOVAIL LABS INTL          30MG                                    N18602 001  Nov 05, 1982    Mar  CAHN
>A>   AB                                 60MG                                    N18602 002  Nov 05, 1982    Mar  CAHN
>A>   AB                                 90MG                                    N18602 003  Dec 08, 1986    Mar  CAHN
>A>   AB  +                              120MG                                   N18602 004  Dec 08, 1986    Mar  CAHN
            DILTIAZEM HCL
>D>   AB      COPLEY PHARM               30MG                                    N74067 001  Nov 05, 1992    Mar  CAHN
>D>   AB                                 60MG                                    N74067 002  Nov 05, 1992    Mar  CAHN
>D>   AB                                 90MG                                    N74067 003  Nov 05, 1992    Mar  CAHN
>D>   AB                                 120MG                                   N74067 004  Nov 05, 1992    Mar  CAHN
>A>   AB      TEVA PHARMS                30MG                                    N74067 001  Nov 05, 1992    Mar  CAHN
>A>   AB                                 60MG                                    N74067 002  Nov 05, 1992    Mar  CAHN
>A>   AB                                 90MG                                    N74067 003  Nov 05, 1992    Mar  CAHN
>A>   AB                                 120MG                                   N74067 004  Nov 05, 1992    Mar  CAHN


        DOXEPIN HYDROCHLORIDE
          CONCENTRATE; ORAL
            DOXEPIN HCL
>D>   AA      COPLEY PHARM               EQ 10MG BASE/ML                         N71609 001  Nov 09, 1987    Mar  CAHN
>A>   AA      TEVA PHARMS                EQ 10MG BASE/ML                         N71609 001  Nov 09, 1987    Mar  CAHN

        DOXYCYCLINE
          CAPSULE; ORAL
            DOXYCYCLINE
>A>   AB      PAR PHARM                  EQ 75MG BASE                            N65055 004  Apr 18, 2005    Mar  NEWA
>D>       +   RANBAXY                    EQ 75MG BASE                            N65053 003  Sep 10, 2003    Mar  CTEC
>A>   AB                                 EQ 75MG BASE                            N65053 003  Sep 10, 2003    Mar  CTEC

        ENALAPRIL MALEATE
          TABLET; ORAL
            VASOTEC
>D>   AB      BIOVAIL                    2.5MG                                   N18998 005  Jul 26, 1988    Mar  CAHN
>D>   AB                                 5MG                                     N18998 001  Dec 24, 1985    Mar  CAHN
>D>   AB                                 10MG                                    N18998 002  Dec 24, 1985    Mar  CAHN
>D>   AB  +                              20MG                                    N18998 003  Dec 24, 1985    Mar  CAHN
>A>   AB      BIOVAIL LABS INTL          2.5MG                                   N18998 005  Jul 26, 1988    Mar  CAHN
>A>   AB                                 5MG                                     N18998 001  Dec 24, 1985    Mar  CAHN
>A>   AB                                 10MG                                    N18998 002  Dec 24, 1985    Mar  CAHN
>A>   AB  +                              20MG                                    N18998 003  Dec 24, 1985    Mar  CAHN

        ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
          TABLET; ORAL
            VASERETIC
>D>   AB      BIOVAIL                    5MG;12.5MG                              N19221 003  Jul 12, 1995    Mar  CAHN
>D>   AB  +                              10MG;25MG                               N19221 001  Oct 31, 1986    Mar  CAHN
>A>   AB      BIOVAIL LABS INTL          5MG;12.5MG                              N19221 003  Jul 12, 1995    Mar  CAHN
>A>   AB  +                              10MG;25MG                               N19221 001  Oct 31, 1986    Mar  CAHN

        ENALAPRILAT
          INJECTABLE; INJECTION
            VASOTEC
>D>   AP  +   BIOVAIL                    1.25MG/ML                               N19309 001  Feb 09, 1988    Mar  CAHN
>A>   AP  +   BIOVAIL LABS INTL          1.25MG/ML                               N19309 001  Feb 09, 1988    Mar  CAHN


>A>     ENTECAVIR
>A>       SOLUTION; ORAL
>A>         BARACLUDE
>A>       +   BRISTOL MYERS              0.05MG/ML                               N21798 001  Mar 29, 2005    Mar  NEWA
>A>       TABLET; ORAL
>A>         BARACLUDE
>A>           BRISTOL MYERS              0.5MG                                   N21797 001  Mar 29, 2005    Mar  NEWA
>A>       +                              1MG                                     N21797 002  Mar 29, 2005    Mar  NEWA


>A>     ESOMEPRAZOLE SODIUM
>A>       INJECTABLE; INTRAVENOUS
>A>         NEXIUM IV
>A>       +   ASTRAZENECA                20MG/VIAL                               N21689 001  Mar 31, 2005    Mar  NEWA
>A>       +                              40MG/VIAL                               N21689 002  Mar 31, 2005    Mar  NEWA

        ESTROGENS, CONJUGATED SYNTHETIC B
>D>       TABLET; ORAL
>D>         ENJUVIA
>A>         @ DURAMED                    0.3MG                                   N21443 001  Dec 20, 2004    Mar  DISC
>A>         @                            0.45MG                                  N21443 002  Dec 20, 2004    Mar  DISC

        ETHINYL ESTRADIOL; NORETHINDRONE
          TABLET; ORAL-21
            NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
>D>   AB  +   WATSON LABS                0.035MG,0.035MG;0.5MG,1MG               N71041 001  Sep 24, 1991    Mar  CTEC
>A>       +                              0.035MG,0.035MG;0.5MG,1MG               N71041 001  Sep 24, 1991    Mar  CTEC
            NORTREL 7/7/7
>D>   AB      BARR                       0.035MG,0.035MG,0.035MG;0.5MG,0.75M     N75478 001  Aug 30, 2002    Mar  CTEC
                                         G,1MG
>A>                                      0.035MG,0.035MG,0.035MG;0.5MG,0.75M     N75478 001  Aug 30, 2002    Mar  CTEC
                                         G,1MG

          TABLET; ORAL-28
            NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
>D>   AB      WATSON LABS                0.035MG,0.035MG;0.5MG,1MG               N71042 001  Sep 24, 1991    Mar  CTEC
>A>                                      0.035MG,0.035MG;0.5MG,1MG               N71042 001  Sep 24, 1991    Mar  CTEC
            ORTHO-NOVUM 10/11-28
>D>   AB      ORTHO MCNEIL               0.035MG,0.035MG;0.5MG,1MG               N18354 002  Jan 11, 1982    Mar  CRLD
>A>   AB  +                              0.035MG,0.035MG;0.5MG,1MG               N18354 002  Jan 11, 1982    Mar  CRLD
            OVCON-35
>D>   AB  +   WARNER CHILCOTT            0.035MG;0.4MG                           N17716 001                  Mar  CRLD
>A>   AB                                 0.035MG;0.4MG                           N17716 001                  Mar  CRLD


        ETHOSUXIMIDE
          SYRUP; ORAL
            ETHOSUXIMIDE
>D>   AA      COPLEY PHARM               250MG/5ML                               N81306 001  Jul 30, 1993    Mar  CAHN
>A>   AA      TEVA PHARMS                250MG/5ML                               N81306 001  Jul 30, 1993    Mar  CAHN

        FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            ALLEGRA-D 12 HOUR
>D>       +   AVENTIS PHARMS             60MG;120MG                              N20786 001  Dec 24, 1997    Mar  CFTG
>A>   AB  +                              60MG;120MG                              N20786 001  Dec 24, 1997    Mar  CFTG
>A>         FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCL
>A>   AB      BARR                       60MG;120MG                              N76236 001  Apr 14, 2005    Mar  NEWA
        FLUCONAZOLE


          INJECTABLE; INJECTION
            FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
>A>   AP      APOTEX                     200MG/100ML                             N76888 001  Mar 25, 2005    Mar  NEWA
            FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A>   AP      APOTEX                     200MG/100ML                             N76889 001  Mar 25, 2005    Mar  NEWA

        FLUOCINONIDE
          SOLUTION; TOPICAL
            FLUOCINONIDE
>D>   AT      COPLEY PHARM               0.05%                                   N72522 001  Sep 28, 1990    Mar  CAHN
>A>   AT      TEVA PHARMS                0.05%                                   N72522 001  Sep 28, 1990    Mar  CAHN


        FLUPHENAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
            FLUPHENAZINE HCL
>D>   AA      COPLEY PHARM               5MG/ML                                  N73058 001  Aug 30, 1991    Mar  CAHN
>A>   AA      TEVA PHARMS                5MG/ML                                  N73058 001  Aug 30, 1991    Mar  CAHN
          ELIXIR; ORAL
            FLUPHENAZINE HCL
>D>   AA      COPLEY PHARM               2.5MG/5ML                               N81310 001  Apr 29, 1993    Mar  CAHN
>A>   AA      TEVA PHARMS                2.5MG/5ML                               N81310 001  Apr 29, 1993    Mar  CAHN


        FLUTICASONE PROPIONATE
>A>       LOTION; TOPICAL
>A>         CUTIVATE
>A>       +   GLAXOSMITHKLINE            0.05%                                   N21152 001  Mar 31, 2005    Mar  NEWA

        FOSINOPRIL SODIUM
          TABLET; ORAL
            FOSINOPRIL SODIUM
>A>   AB      INVAGEN PHARMS             10MG                                    N77222 001  Apr 20, 2005    Mar  NEWA
>A>   AB                                 20MG                                    N77222 002  Apr 20, 2005    Mar  NEWA
>A>   AB                                 40MG                                    N77222 003  Apr 20, 2005    Mar  NEWA

        GABAPENTIN
          CAPSULE; ORAL
            GABAPENTIN
>A>   AB      APOTEX                     100MG                                   N75360 001  Apr 06, 2005    Mar  NEWA
>A>   AB                                 300MG                                   N75360 002  Apr 06, 2005    Mar  NEWA
>A>   AB                                 400MG                                   N75360 003  Apr 06, 2005    Mar  NEWA
>A>   AB      EON                        100MG                                   N75539 001  Apr 06, 2005    Mar  NEWA
>A>   AB                                 300MG                                   N75539 002  Apr 06, 2005    Mar  NEWA
>A>   AB                                 400MG                                   N75539 003  Apr 06, 2005    Mar  NEWA
>A>   AB      IVAX PHARMS                100MG                                   N75477 001  Mar 23, 2005    Mar  NEWA
>A>   AB                                 300MG                                   N75477 002  Mar 23, 2005    Mar  NEWA
>A>   AB                                 400MG                                   N75477 003  Mar 23, 2005    Mar  NEWA


        GATIFLOXACIN
          INJECTABLE; INJECTION
            TEQUIN
>D>       +   BRISTOL MYERS              EQ 2MG /ML(200MG/100ML)                 N21062 001  Dec 17, 1999    Mar  CPOT
>D>       +                              EQ 2MG /ML(400MG/200ML)                 N21062 002  Dec 17, 1999    Mar  CPOT
>D>       +                              EQ 10MG /ML(400MG)                      N21062 004  Dec 17, 1999    Mar  CPOT
>A>       +                              400MG/40ML(10MG/ML)                     N21062 004  Dec 17, 1999    Mar  CPOT

            TEQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>A>       +   BRISTOL MYERS              200MG/100ML(2MG/ML)                     N21062 001  Dec 17, 1999    Mar  CPOT
>A>       +                              400MG/200ML(2MG/ML)                     N21062 002  Dec 17, 1999    Mar  CPOT

        GUANABENZ ACETATE
          TABLET; ORAL
            GUANABENZ ACETATE
>D>   AB      COPLEY PHARM               EQ 4MG BASE                             N74267 001  Jun 01, 1994    Mar  CAHN
>D>   AB                                 EQ 8MG BASE                             N74267 002  Jun 01, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 4MG BASE                             N74267 001  Jun 01, 1994    Mar  CAHN
>A>   AB                                 EQ 8MG BASE                             N74267 002  Jun 01, 1994    Mar  CAHN

        HALOPERIDOL LACTATE
          CONCENTRATE; ORAL
            HALOPERIDOL

>D>   AA  +   COPLEY PHARM               EQ 2MG BASE/ML                          N71617 001  Dec 01, 1988    Mar  CAHN
>A>   AA  +   TEVA PHARMS                EQ 2MG BASE/ML                          N71617 001  Dec 01, 1988    Mar  CAHN

        HYDROCHLOROTHIAZIDE; IRBESARTAN
          TABLET; ORAL
            AVALIDE
>D>       +   SANOFI                     12.5MG;300MG                            N20758 003  Aug 31, 1998    Mar  CRLD
>A>                                      12.5MG;300MG                            N20758 003  Aug 31, 1998    Mar  CRLD
>A>       +                              25MG;300MG                              N20758 004  Mar 15, 2005    Mar  NEWA

        HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
          TABLET; ORAL
>A>         QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE
>A>   AB      MYLAN                      12.5MG;EQ 10MG BASE                     N77093 001  Mar 28, 2005    Mar  NEWA
>A>   AB                                 12.5MG;EQ 20MG BASE                     N77093 002  Mar 28, 2005    Mar  NEWA
>A>   AB                                 25MG;EQ 20MG BASE                       N77093 003  Mar 28, 2005    Mar  NEWA


        HYDROCHLOROTHIAZIDE; VALSARTAN
          TABLET; ORAL
            DIOVAN HCT
>D>       +   NOVARTIS                   12.5MG;160MG                            N20818 002  Mar 06, 1998    Mar  CRLD
>A>                                      12.5MG;160MG                            N20818 002  Mar 06, 1998    Mar  CRLD
>D>                                      25MG;160MG                              N20818 003  Jan 17, 2002    Mar  CRLD
>A>       +                              25MG;160MG                              N20818 003  Jan 17, 2002    Mar  CRLD


        HYDROCORTISONE
          ENEMA; RECTAL
            HYDROCORTISONE
>D>   AB      COPLEY PHARM               100MG/60ML                              N74171 001  May 27, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                100MG/60ML                              N74171 001  May 27, 1994    Mar  CAHN


        HYDROCORTISONE VALERATE
          CREAM; TOPICAL
            HYDROCORTISONE VALERATE
>D>   AB      COPLEY PHARM               0.2%                                    N74489 001  Aug 12, 1998    Mar  CAHN
>A>   AB      TEVA PHARMS                0.2%                                    N74489 001  Aug 12, 1998    Mar  CAHN

        HYDROXYCHLOROQUINE SULFATE
          TABLET; ORAL
            HYDROXYCHLOROQUINE SULFATE
>D>   AB      COPLEY PHARM               200MG                                   N40081 001  Sep 30, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                200MG                                   N40081 001  Sep 30, 1994    Mar  CAHN


        HYDROXYPROGESTERONE CAPROATE
          INJECTABLE; INJECTION
            HYDROXYPROGESTERONE CAPROATE
>D>         @ STERIS                     125MG/ML                                N17439 001                  Mar  CAHN
>D>         @                            250MG/ML                                N17439 002                  Mar  CAHN
>A>         @ WATSON LABS                125MG/ML                                N17439 001                  Mar  CAHN
>A>         @                            250MG/ML                                N17439 002                  Mar  CAHN


        IBANDRONATE SODIUM
          TABLET; ORAL
            BONIVA
>A>           ROCHE                      EQ 150MG BASE                           N21455 002  Mar 24, 2005    Mar  NEWA

        IRON SUCROSE
          INJECTABLE; INTRAVENOUS
            VENOFER
>D>       +   LUITPOLD                   EQ 20MG BASE/ML                         N21135 001  Nov 06, 2000    Mar  CPOT
>A>       +                              EQ 100MG BASE/5ML(EQ 20MG BASE/ML)      N21135 001  Nov 06, 2000    Mar  CPOT
>A>                                      EQ 50MG BASE/2.5ML(EQ 20MG              N21135 002  Mar 20, 2005    Mar  NEWA
>A>                                      EQ 75MG BASE/3.75ML(EQ 20MG             N21135 003  Mar 29, 2005    Mar  NEWA

        ISRADIPINE
          TABLET, EXTENDED RELEASE; ORAL
            DYNACIRC CR
>D>       +   RELIANT PHARMS             5MG                                     N20336 001  Jun 01, 1994    Mar  CRLD
>A>                                      5MG                                     N20336 001  Jun 01, 1994    Mar  CRLD
        KETOCONAZOLE


          SHAMPOO; TOPICAL
            KETOCONAZOLE
>A>   AB      QLT USA                    2%                                      N76942 001  Apr 11, 2005    Mar  NEWA

        LACTULOSE
          SOLUTION; ORAL
            EVALOSE
>D>   AA      COPLEY PHARM               10GM/15ML                               N73497 001  May 28, 1993    Mar  CAHN
>A>   AA      TEVA PHARMS                10GM/15ML                               N73497 001  May 28, 1993    Mar  CAHN
          SOLUTION; ORAL, RECTAL
            HEPTALAC
>D>   AA      COPLEY PHARM               10GM/15ML                               N73504 001  May 28, 1993    Mar  CAHN
>A>   AA      TEVA PHARMS                10GM/15ML                               N73504 001  May 28, 1993    Mar  CAHN
>D>     LEPIRUDIN
>D>       INJECTABLE; INJECTION
>D>         REFLUDAN
>D>       +   BERLEX                     50MG/VIAL                               N20807 001  Mar 06, 1998    Mar  CAIN


>A>     LEPIRUDIN RECOMBINANT
>A>       INJECTABLE; INJECTION
>A>         REFLUDAN
>A>       +   BERLEX                     50MG/VIAL                               N20807 001  Mar 06, 1998    Mar  CAIN

        LEVALBUTEROL TARTRATE
>A>       AEROSOL, METERED; INHALATION
>A>         XOPENEX HFA
>A>       +   SEPRACOR                   EQ 0.045MG BASE/INH                     N21730 001  Mar 11, 2005    Mar  NEWA


        LEVOFLOXACIN
          TABLET; ORAL
            LEVAQUIN
>D>   AB      ORTHO MCNEIL               250MG                                   N20634 001  Dec 20, 1996    Mar  CTEC
>A>                                      250MG                                   N20634 001  Dec 20, 1996    Mar  CTEC
>D>   AB                                 500MG                                   N20634 002  Dec 20, 1996    Mar  CTEC
>A>                                      500MG                                   N20634 002  Dec 20, 1996    Mar  CTEC


        LIDOCAINE HYDROCHLORIDE
          JELLY; TOPICAL
            LIDOCAINE HCL
>D>   AT      COPLEY PHARM               2%                                      N81318 001  Apr 29, 1993    Mar  CAHN
>A>   AT      TEVA PHARMS                2%                                      N81318 001  Apr 29, 1993    Mar  CAHN

        MEBENDAZOLE
          TABLET, CHEWABLE; ORAL
            MEBENDAZOLE
>D>   AB      COPLEY PHARM               100MG                                   N73580 001  Jan 04, 1995    Mar  CAHN
>A>   AB      TEVA PHARMS                100MG                                   N73580 001  Jan 04, 1995    Mar  CAHN


        MEGESTROL ACETATE
          SUSPENSION; ORAL
            MEGESTROL ACETATE
>D>   AB      COPLEY PHARM               40MG/ML                                 N75681 001  May 05, 2003    Mar  CAHN
>A>   AB      TEVA PHARMS                40MG/ML                                 N75681 001  May 05, 2003    Mar  CAHN


        METAPROTERENOL SULFATE
          SYRUP; ORAL
            METAPROTERENOL SULFATE
>D>         @ COPLEY PHARM               10MG/5ML                                N73034 001  Aug 30, 1991    Mar  CAHN
>A>         @ TEVA PHARMS                10MG/5ML                                N73034 001  Aug 30, 1991    Mar  CAHN

        METFORMIN HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            METFORMIN HCL
>A>   AB      ANDRX PHARMS               750MG                                   N76869 001  Apr 12, 2005    Mar  NEWA
>A>   AB      PUREPAC PHARM              750MG                                   N76878 001  Apr 13, 2005    Mar  NEWA
>A>   AB      TEVA                       750MG                                   N76864 001  Apr 12, 2005    Mar  NEWA
>A>   AB      ZYDUS PHARMS USA           500MG                                   N77060 001  Apr 20, 2005    Mar  NEWA
          TABLET; ORAL
            METFORMIN HCL

>A>   AB      ZYDUS PHARMS USA           500MG                                   N77064 001  Apr 18, 2005    Mar  NEWA
>A>   AB                                 850MG                                   N77064 002  Apr 18, 2005    Mar  NEWA
>A>   AB                                 1GM                                     N77064 003  Apr 18, 2005    Mar  NEWA

        METHAZOLAMIDE
          TABLET; ORAL
            METHAZOLAMIDE
>D>   AB      COPLEY PHARM               25MG                                    N40001 001  Jun 30, 1993    Mar  CAHN
>D>   AB                                 50MG                                    N40001 002  Jun 30, 1993    Mar  CAHN
>A>   AB      TEVA PHARMS                25MG                                    N40001 001  Jun 30, 1993    Mar  CAHN
>A>   AB                                 50MG                                    N40001 002  Jun 30, 1993    Mar  CAHN

        METOLAZONE
          TABLET; ORAL
            ZAROXOLYN
>D>   AB      CELLTECH PHARMS            2.5MG                                   N17386 001                  Mar  CAHN
>D>   AB  +                              5MG                                     N17386 002                  Mar  CAHN
>D>   AB  +                              10MG                                    N17386 003                  Mar  CAHN
>A>   AB      UCB                        2.5MG                                   N17386 001                  Mar  CAHN
>A>   AB  +                              5MG                                     N17386 002                  Mar  CAHN
>A>   AB  +                              10MG                                    N17386 003                  Mar  CAHN


        METOPROLOL TARTRATE
          TABLET; ORAL
            METOPROLOL TARTRATE
>D>   AB      COPLEY PHARM               50MG                                    N74333 001  Jan 27, 1994    Mar  CAHN
>D>   AB                                 100MG                                   N74333 002  Jan 27, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                50MG                                    N74333 001  Jan 27, 1994    Mar  CAHN
>A>   AB                                 100MG                                   N74333 002  Jan 27, 1994    Mar  CAHN


>A>     MICAFUNGIN SODIUM
>A>       INJECTABLE; IV (INFUSION)
>A>         MYCAMINE
>A>       +   ASTELLAS                   50MG/VIAL                               N21506 002  Mar 16, 2005    Mar  NEWA

        MIDAZOLAM HYDROCHLORIDE
          INJECTABLE; INJECTION
            MIDAZOLAM HCL
>D>         @ HOSPIRA                    EQ 1MG BASE/ML                          N75293 001  Jun 20, 2000    Mar  CMFD
>A>   AP                                 EQ 1MG BASE/ML                          N75293 001  Jun 20, 2000    Mar  CMFD
>D>         @                            EQ 5MG BASE/ML                          N75293 002  Jun 20, 2000    Mar  CMFD
>A>   AP                                 EQ 5MG BASE/ML                          N75293 002  Jun 20, 2000    Mar  CMFD

        MOMETASONE FUROATE
          CREAM; TOPICAL
            MOMETASONE FUROATE
>A>   AB      ALTANA                     0.1%                                    N76171 001  Apr 08, 2005    Mar  NEWA
          LOTION; TOPICAL
            ELOCON
>D>       +   SCHERING                   0.1%                                    N19796 001  Mar 30, 1989    Mar  CFTG
>A>   AB  +                              0.1%                                    N19796 001  Mar 30, 1989    Mar  CFTG

>A>         MOMETASONE FUROATE
>A>   AB      AGIS INDS                  0.1%                                    N77180 001  Apr 06, 2005    Mar  NEWA
          OINTMENT; TOPICAL
            MOMETASONE FUROATE
>A>   AB      ALTANA                     0.1%                                    N77061 001  Mar 28, 2005    Mar  NEWA
>A>       POWDER; INHALATION
>A>         ASMANEX TWISTHALER
>A>       +   SCHERING                   0.22MG/INH                              N21067 001  Mar 30, 2005    Mar  NEWA

        MOMETASONE FUROATE MONOHYDRATE
          SPRAY, METERED; NASAL
            NASONEX
>D>       +   SCHERING PLOUGH            EQ 0.05MG BASE/SPRAY                    N20762 001  Oct 01, 1997    Mar  CAHN
>A>       +   SHIRE                      EQ 0.05MG BASE/SPRAY                    N20762 001  Oct 01, 1997    Mar  CAHN

        MORPHINE SULFATE
          CAPSULE, EXTENDED RELEASE; ORAL
            AVINZA
>D>   BX  +   LIGAND                     30MG                                    N21260 001  Mar 20, 2002    Mar  CRLD
>A>   BX      LIGAND                     30MG                                    N21260 001  Mar 20, 2002    Mar  CRLD
>D>   BX  +                              60MG                                    N21260 002  Mar 20, 2002    Mar  CRLD
>A>   BX                                 60MG                                    N21260 002  Mar 20, 2002    Mar  CRLD
>D>       +                              90MG                                    N21260 003  Mar 20, 2002    Mar  CRLD
>A>                                      90MG                                    N21260 003  Mar 20, 2002    Mar  CRLD
            KADIAN
>D>       +   ALPHARMA US                20MG                                    N20616 001  Jul 03, 1996    Mar  CRLD

>A>                                      20MG                                    N20616 001  Jul 03, 1996    Mar  CRLD
>D>   BX  +                              30MG                                    N20616 004  Mar 09, 2001    Mar  CRLD
>A>   BX                                 30MG                                    N20616 004  Mar 09, 2001    Mar  CRLD
>D>       +                              50MG                                    N20616 002  Jul 03, 1996    Mar  CRLD
>A>                                      50MG                                    N20616 002  Jul 03, 1996    Mar  CRLD
>D>   BX  +                              60MG                                    N20616 005  Mar 09, 2001    Mar  CRLD
>A>   BX                                 60MG                                    N20616 005  Mar 09, 2001    Mar  CRLD


        NADOLOL
          TABLET; ORAL
            NADOLOL
>D>   AB      COPLEY PHARM               80MG                                    N74368 001  Aug 31, 1994    Mar  CAHN
>D>   AB                                 120MG                                   N74368 002  Aug 31, 1994    Mar  CAHN
>D>   AB                                 160MG                                   N74368 003  Aug 31, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                80MG                                    N74368 001  Aug 31, 1994    Mar  CAHN
>A>   AB                                 120MG                                   N74368 002  Aug 31, 1994    Mar  CAHN
>A>   AB                                 160MG                                   N74368 003  Aug 31, 1994    Mar  CAHN

        NALOXONE HYDROCHLORIDE
          INJECTABLE; INJECTION
            NALOXONE HCL
>D>         @ HOSPIRA                    0.4MG/ML                                N70172 001  Sep 24, 1986    Mar  CMFD
>A>   AP                                 0.4MG/ML                                N70172 001  Sep 24, 1986    Mar  CMFD


        NAPROXEN
          TABLET; ORAL
            NAPROXEN
>D>   AB      COPLEY PHARM               250MG                                   N74207 001  Dec 21, 1993    Mar  CAHN
>D>   AB                                 375MG                                   N74207 002  Dec 21, 1993    Mar  CAHN
>D>   AB                                 500MG                                   N74207 003  Dec 21, 1993    Mar  CAHN
>A>   AB      TEVA PHARMS                250MG                                   N74207 001  Dec 21, 1993    Mar  CAHN
>A>   AB                                 375MG                                   N74207 002  Dec 21, 1993    Mar  CAHN
>A>   AB                                 500MG                                   N74207 003  Dec 21, 1993    Mar  CAHN

        NAPROXEN SODIUM
          TABLET; ORAL
            NAPROXEN SODIUM
>D>   AB      COPLEY PHARM               EQ 250MG BASE                           N74289 001  Jan 27, 1994    Mar  CAHN
>D>   AB                                 EQ 500MG BASE                           N74289 002  Jan 27, 1994    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 250MG BASE                           N74289 001  Jan 27, 1994    Mar  CAHN
>A>   AB                                 EQ 500MG BASE                           N74289 002  Jan 27, 1994    Mar  CAHN

        NIACIN
          TABLET, EXTENDED RELEASE; ORAL
>A>         NIACIN
>A>   AB      BARR                       1GM                                     N76250 001  Apr 14, 2005    Mar  NEWA
            NIASPAN
>D>       +   KOS                        1GM                                     N20381 004  Jul 28, 1997    Mar  CFTG
>A>   AB  +                              1GM                                     N20381 004  Jul 28, 1997    Mar  CFTG


        NICARDIPINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            CARDENE
>A>       +   ESP PHARMA                 2.5MG/ML                                N19734 001  Jan 30, 1992    Mar  CAHN
>D>       +   ROCHE PALO                 2.5MG/ML                                N19734 001  Jan 30, 1992    Mar  CAHN


        NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
          CAPSULE; ORAL
            NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
>A>   AB      EON                        75MG;25MG                               N77066 001  Apr 05, 2005    Mar  NEWA
>A>   AB      RANBAXY                    75MG;25MG                               N76951 001  Mar 30, 2005    Mar  NEWA
        OCTREOTIDE ACETATE


          INJECTABLE; INJECTION
>A>         OCTREOTIDE ACETATE
>A>   AP      BEDFORD                    EQ 0.2MG BASE/ML                        N76330 001  Apr 08, 2005    Mar  NEWA
>A>   AP                                 EQ 1MG BASE/ML                          N76330 002  Apr 08, 2005    Mar  NEWA
>A>         OCTREOTIDE ACETATE (PRESERVATIVE FREE)
>A>   AP      BEDFORD                    EQ 0.05MG BASE/ML                       N76313 001  Mar 28, 2005    Mar  NEWA
>A>   AP                                 EQ 0.1MG BASE/ML                        N76313 003  Mar 28, 2005    Mar  NEWA
>A>   AP                                 EQ 0.5MG BASE/ML                        N76313 002  Mar 28, 2005    Mar  NEWA
            SANDOSTATIN
>D>       +   NOVARTIS                   EQ 0.05MG BASE/ML                       N19667 001  Oct 21, 1988    Mar  CFTG
>A>   AP  +                              EQ 0.05MG BASE/ML                       N19667 001  Oct 21, 1988    Mar  CFTG
>D>       +                              EQ 0.1MG BASE/ML                        N19667 002  Oct 21, 1988    Mar  CFTG
>A>   AP  +                              EQ 0.1MG BASE/ML                        N19667 002  Oct 21, 1988    Mar  CFTG
>D>       +                              EQ 0.2MG BASE/ML                        N19667 004  Jun 12, 1991    Mar  CFTG
>A>   AP  +                              EQ 0.2MG BASE/ML                        N19667 004  Jun 12, 1991    Mar  CFTG
>D>       +                              EQ 0.5MG BASE/ML                        N19667 003  Oct 21, 1988    Mar  CFTG
>A>   AP  +                              EQ 0.5MG BASE/ML                        N19667 003  Oct 21, 1988    Mar  CFTG
>D>       +                              EQ 1MG BASE/ML                          N19667 005  Jun 12, 1991    Mar  CFTG
>A>   AP  +                              EQ 1MG BASE/ML                          N19667 005  Jun 12, 1991    Mar  CFTG

        OLSALAZINE SODIUM
          CAPSULE; ORAL
            DIPENTUM
>D>       +   CELLTECH PHARMS            250MG                                   N19715 001  Jul 31, 1990    Mar  CAHN
>A>       +   UCB                        250MG                                   N19715 001  Jul 31, 1990    Mar  CAHN


        OMEPRAZOLE
          CAPSULE, DELAYED REL PELLETS; ORAL
            PRILOSEC
>D>   AB  +   ASTRAZENECA                40MG                                    N19810 002  Jan 15, 1998    Mar  CTEC
>A>                                      40MG                                    N19810 002  Jan 15, 1998    Mar  CTEC


        OXALIPLATIN
          INJECTABLE; IV (INFUSION)
            ELOXATIN
>D>           SANOFI                     50MG/VIAL                               N21492 001  Aug 09, 2002    Mar  CRLD
>A>       +                              50MG/VIAL                               N21492 001  Aug 09, 2002    Mar  CRLD

        PEMOLINE
          TABLET, CHEWABLE; ORAL
            PEMOLINE
>D>   AB      COPLEY PHARM               37.5MG                                  N75555 001  Feb 18, 2000    Mar  CAHN
>A>   AB      TEVA PHARMS                37.5MG                                  N75555 001  Feb 18, 2000    Mar  CAHN

          TABLET; ORAL
            PEMOLINE
>D>   AB      COPLEY PHARM               18.75MG                                 N75030 003  Feb 22, 2000    Mar  CAHN
>D>   AB                                 37.5MG                                  N75030 001  Jan 29, 1999    Mar  CAHN
>D>   AB                                 75MG                                    N75030 002  Jan 29, 1999    Mar  CAHN
>A>   AB      TEVA PHARMS                18.75MG                                 N75030 003  Feb 22, 2000    Mar  CAHN
>A>   AB                                 37.5MG                                  N75030 001  Jan 29, 1999    Mar  CAHN
>A>   AB                                 75MG                                    N75030 002  Jan 29, 1999    Mar  CAHN


        PHENTERMINE HYDROCHLORIDE
          TABLET; ORAL
            PHENTERMINE HCL
>A>   AA      LANNETT                    37.5MG                                  N40555 001  Apr 15, 2005    Mar  NEWA

        PHENTERMINE RESIN COMPLEX
          CAPSULE, EXTENDED RELEASE; ORAL
            IONAMIN
>D>           CELLTECH PHARMS            EQ 15MG BASE                            N11613 004                  Mar  CAHN
>D>       +                              EQ 30MG BASE                            N11613 002                  Mar  CAHN
>A>           UCB                        EQ 15MG BASE                            N11613 004                  Mar  CAHN
>A>       +                              EQ 30MG BASE                            N11613 002                  Mar  CAHN

        PHENYTOIN SODIUM
          INJECTABLE; INJECTION
            PHENYTOIN
>D>       +   ELKINS SINN                50MG/ML                                 N84307 001                  Mar  CTEC

>A>   AP  +   ELKINS SINN                50MG/ML                                 N84307 001                  Mar  CTEC
            PHENYTOIN SODIUM
>D>         @ HOSPIRA                    50MG/ML                                 N89744 001  Dec 18, 1987    Mar  CMFD
>A>   AP                                 50MG/ML                                 N89744 001  Dec 18, 1987    Mar  CMFD
>D>         @                            50MG/ML                                 N89521 001  Mar 17, 1987    Mar  CMFD
>A>   AP                                 50MG/ML                                 N89521 001  Mar 17, 1987    Mar  CMFD


        PIROXICAM
          CAPSULE; ORAL
            PIROXICAM
>D>   AB      COPLEY PHARM               10MG                                    N74103 001  Aug 28, 1992    Mar  CAHN
>D>   AB                                 20MG                                    N74103 002  Aug 28, 1992    Mar  CAHN
>A>   AB      TEVA PHARMS                10MG                                    N74103 001  Aug 28, 1992    Mar  CAHN
>A>   AB                                 20MG                                    N74103 002  Aug 28, 1992    Mar  CAHN


        POTASSIUM CHLORIDE
          INJECTABLE; INJECTION
            POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
>D>         @ HOSPIRA                    14.9MG/ML                               N20161 005  Nov 30, 1992    Mar  CMFD
>A>   AP                                 14.9MG/ML                               N20161 005  Nov 30, 1992    Mar  CMFD
>D>         @                            745MG/100ML                             N20161 001  Nov 30, 1992    Mar  CMFD
>A>   AP                                 745MG/100ML                             N20161 001  Nov 30, 1992    Mar  CMFD
            POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
>D>         @ HOSPIRA                    1.49GM/100ML                            N20161 002  Nov 30, 1992    Mar  CMFD
>A>   AP                                 1.49GM/100ML                            N20161 002  Nov 30, 1992    Mar  CMFD


>A>     PRAMLINTIDE ACETATE
>A>       INJECTABLE; SUBCUTANEOUS
>A>         SYMLIN
>A>       +   AMYLIN                     EQ 3MG BASE/5ML (EQ 0.6MG BASE/ML)      N21332 001  Mar 16, 2005    Mar  NEWA

        PREDNISOLONE
          SYRUP; ORAL
            PREDNISOLONE
>D>   AA      COPLEY PHARM               15MG/5ML                                N40322 001  Jan 19, 2000    Mar  CAHN
>A>   AA      TEVA PHARMS                15MG/5ML                                N40322 001  Jan 19, 2000    Mar  CAHN

        PREDNISOLONE SODIUM PHOSPHATE
          SOLUTION; ORAL
            PEDIAPRED
>D>   AA  +   CELLTECH PHARMS            EQ 5MG BASE/5ML                         N19157 001  May 28, 1986    Mar  CAHN
>A>   AA  +   UCB                        EQ 5MG BASE/5ML                         N19157 001  May 28, 1986    Mar  CAHN


        PROCHLORPERAZINE MALEATE
          TABLET; ORAL
            PROCHLORPERAZINE MALEATE
>D>   AB      COPLEY PHARM               EQ 5MG BASE                             N40120 001  Jul 11, 1996    Mar  CAHN
>D>   AB                                 EQ 10MG BASE                            N40120 002  Jul 11, 1996    Mar  CAHN
>A>   AB      TEVA PHARMS                EQ 5MG BASE                             N40120 001  Jul 11, 1996    Mar  CAHN
>A>   AB                                 EQ 10MG BASE                            N40120 002  Jul 11, 1996    Mar  CAHN


        PROPOFOL
          INJECTABLE; INJECTION
            PROPOFOL
>A>   AB      BEDFORD                    10MG/ML                                 N74848 001  Apr 19, 2005    Mar  NEWA

        QUINIDINE SULFATE
          TABLET, EXTENDED RELEASE; ORAL
            QUINIDINE SULFATE
>D>       +   COPLEY PHARM               300MG                                   N40045 001  Jun 30, 1994    Mar  CAHN
>A>       +   TEVA PHARMS                300MG                                   N40045 001  Jun 30, 1994    Mar  CAHN


        SODIUM CHLORIDE
          SOLUTION; IRRIGATION
            SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D>         @ HOSPIRA                    450MG/100ML                             N18380 001                  Mar  CMFD
>A>   AT                                 450MG/100ML                             N18380 001                  Mar  CMFD


>D>     SOMATREM
>D>       INJECTABLE; INJECTION
>D>         PROTROPIN


>D>       +   GENENTECH                  5MG/VIAL                                N19107 001  Oct 17, 1985    Mar  DISC
>A>         @                            5MG/VIAL                                N19107 001  Oct 17, 1985    Mar  DISC
>D>       +                              10MG/VIAL                               N19107 002  Oct 24, 1989    Mar  DISC
>A>         @                            10MG/VIAL                               N19107 002  Oct 24, 1989    Mar  DISC


        TERBUTALINE SULFATE
          TABLET; ORAL
            TERBUTALINE SULFATE
>A>   AB      LANNETT                    2.5MG                                   N77152 001  Mar 25, 2005    Mar  NEWA
>A>   AB                                 5MG                                     N77152 002  Mar 25, 2005    Mar  NEWA

        TETRACYCLINE HYDROCHLORIDE
          CAPSULE; ORAL
>D>         SUMYCIN
>D>   AB      APOTHECON                  250MG                                   N60429 001                  Mar  DISC
>A>         @                            250MG                                   N60429 001                  Mar  DISC

>D>   AB  +                              500MG                                   N60429 003                  Mar  DISC
>A>         @                            500MG                                   N60429 003                  Mar  DISC
            TETRACYCLINE HCL
>D>   AB      IVAX PHARMS                500MG                                   N60704 002                  Mar  CRLD
>A>   AB  +                              500MG                                   N60704 002                  Mar  CRLD


        THIORIDAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
            THIORIDAZINE HCL
>D>   AA  +   COPLEY PHARM               30MG/ML                                 N89602 001  Nov 09, 1987    Mar  CAHN
>D>   AA  +                              100MG/ML                                N89603 001  Nov 09, 1987    Mar  CAHN
>A>   AA  +   TEVA PHARMS                30MG/ML                                 N89602 001  Nov 09, 1987    Mar  CAHN
>A>   AA  +                              100MG/ML                                N89603 001  Nov 09, 1987    Mar  CAHN

        THIOTHIXENE HYDROCHLORIDE
          CONCENTRATE; ORAL
            THIOTHIXENE HCL
>D>   AA      COPLEY PHARM               EQ 5MG BASE/ML                          N71554 001  Oct 16, 1987    Mar  CAHN
>A>   AA      TEVA PHARMS                EQ 5MG BASE/ML                          N71554 001  Oct 16, 1987    Mar  CAHN

        TRETINOIN
          SOLUTION; TOPICAL
            TRETINOIN
>D>   AT      COPLEY PHARM               0.05%                                   N74873 001  Jun 19, 1998    Mar  CAHN
>A>   AT      TEVA PHARMS                0.05%                                   N74873 001  Jun 19, 1998    Mar  CAHN


        URSODIOL
          CAPSULE; ORAL
            URSODIOL
>D>   AB      COPLEY PHARM               300MG                                   N75592 001  May 25, 2000    Mar  CAHN
>A>   AB      TEVA PHARMS                300MG                                   N75592 001  May 25, 2000    Mar  CAHN

        VALPROIC ACID
          SYRUP; ORAL
            VALPROIC ACID
>D>   AA      COPLEY PHARM               250MG/5ML                               N73178 001  Aug 25, 1992    Mar  CAHN
>A>   AA      TEVA PHARMS                250MG/5ML                               N73178 001  Aug 25, 1992    Mar  CAHN

        VERAPAMIL HYDROCHLORIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            VERELAN PM
>D>       +   ELAN PHARM                 100MG                                   N20943 001  Nov 25, 1998    Mar  CRLD
>A>                                      100MG                                   N20943 001  Nov 25, 1998    Mar  CRLD
>D>       +                              200MG                                   N20943 002  Nov 25, 1998    Mar  CRLD
>A>                                      200MG                                   N20943 002  Nov 25, 1998    Mar  CRLD

        VINORELBINE TARTRATE
          INJECTABLE; INJECTION
            VINORELBINE TARTRATE
>A>   AP      AM PHARM                   EQ 10MG BASE/ML                         N76849 001  Apr 18, 2005    Mar  NEWA




ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

       ASPIRIN
          TABLET; ORAL
            BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
>D>         @ BAYER                      500MG                                   N21317 001  Oct 18, 2001    Mar  CMFD
>A>                                      500MG                                   N21317 001  Oct 18, 2001    Mar  CMFD


        CLOTRIMAZOLE
          TABLET; VAGINAL
            GYNIX
>D>           COPLEY PHARM               100MG                                   N73249 001  Feb 13, 1998    Mar  CAHN
>A>           TEVA PHARMS                100MG                                   N73249 001  Feb 13, 1998    Mar  CAHN

        FAMOTIDINE
          TABLET; ORAL
            FAMOTIDINE
>A>           PERRIGO                    10MG                                    N75400 001  Mar 18, 2005    Mar  NEWA

 

 
-